e-learning
resources
Madrid 2019
Sunday, 29.09.2019
Evaluation of basic science in airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis
C. Chang (Beijing, China), Y. Liang (Beijing, China), J. Wang (Beijing, China), Y. Sun (Beijing, China), W. Yao (Beijing, China)
Source:
International Congress 2019 – Evaluation of basic science in airway diseases
Session:
Evaluation of basic science in airway diseases
Session type:
Poster Discussion
Number:
1701
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Chang (Beijing, China), Y. Liang (Beijing, China), J. Wang (Beijing, China), Y. Sun (Beijing, China), W. Yao (Beijing, China). Metabolomic profiling differences among asthma, COPD and healthy controls: a LC-MS-based metabolomics analysis. 1701
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Altered serum metabolomics in COPD: analysis of the SPIROMICS cohort
Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Year: 2018
Metabolomic fingerprinting in the identification of biomarkers in COPD patients
Source: Annual Congress 2012 - Basic and translational studies in COPD
Year: 2012
Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes
Source: Annual Congress 2013 –COPD mechanisms
Year: 2013
High-throughput analysis of induced sputum from the U-BIOPRED study using novel proteomic and data mining approaches
Source: Annual Congress 2013 –Origins and diagnosis of asthma
Year: 2013
Gene signalling heterogeneity in exacerbations of COPD determined by microarray analysis of PBMC mRNA
Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey
Year: 2015
A CADSET WP4 transcriptomic analysis of Asthma and COPD overlap
Source: Virtual Congress 2020 – Asthma science: novel targets and mechanisms
Year: 2020
GC MS based untargeted metabolomics for understanding the pathophysiology of asthma COPD overlap (ACO)
Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Year: 2018
Microarray profiling of COPD patients versus non-COPD smokers reveals possible disease biomarkers
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013
COPD phenotypes revealed by the integrated sputum microbiome and proteome analysis in COPDMAP cohort
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019
Mass spectrometry proteomic biomarkers identify acute COPD exacerbations
Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Year: 2020
A NMR-based metabolomics approach to the assessment of inhaled pharmacotherapy in patients with COPD
Source: International Congress 2019 – Basic research of airway diseases
Year: 2019
Selection of protein expression signatures by interfacing pathophysiology and proteomics technology in smokers and never-smokers
Source: Eur Respir J 2005; 26: Suppl. 49, 441s
Year: 2005
A comparative proteomic profiling of the human erythrocyte membrane in COPD patients
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009
Preliminary proteomics analysis for sepsis biomarkers with iTRAQ labeling and LC-MS/MS
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013
Metabolomic analysis of severe COPD. Study of biomarkers in the CHAIN cohort.
Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency
Year: 2019
Cluster analysis to identify phenotypes in COPD
Source: Annual Congress 2009 - Quality of life and symptoms in COPD
Year: 2009
Further resolution of non-T2 asthma subtypes from high-throughput sputum transciptomics data in U-BIOPRED
Source: International Congress 2018 – Innovative therapies in asthma and COPD
Year: 2018
Transcriptome profiling of platelets from patients with severe asthma.
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Year: 2021
Discrimination of sepsis metabolic profiles revealed by LC/MS-MS based metabonomics approach
Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept